IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
20 hedge funds and large institutions have $464K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$74K |
| 2 |
2
Renaissance Technologies
New York
|
$280K |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$3K |
| 4 |
RCAG
4
Rehmann Capital Advisory Group
Lansing,
Michigan
|
$18 |
